Recombinant Human CCRL2 Protein，His

CCRL2, or Chemokine Chemokine Receptor-Like 2, is a receptor belonging to the G protein-coupled receptor family, which plays a crucial role in immune system regulation and inflammation. As a chemokine receptor, CCRL2 is involved in the recruitment and activation of immune cells in response to various stimuli. Research into CCRL2 has gained momentum due to its potential implications in several pathological conditions, including autoimmune diseases, cancer, and infectious diseases. In particular, the expression of CCRL2 in different immune cell populations and its role in modulating immune responses have garnered attention, as it may offer new insights into therapeutic targets for immunological disorders. The study of CCRL2 recombinant proteins is pivotal in elucidating its functional mechanisms and signaling pathways. By producing CCRL2 as a recombinant protein, researchers aim to investigate its ligand-binding capabilities, the effects of receptor activation on downstream signaling, and its interactions with other cellular components. These studies not only contribute to the fundamental understanding of CCRL2's role in immune responses but also provide a foundation for developing targeted therapies that could modulate immune activity in various diseases. Furthermore, the recombinant CCRL2 protein can serve as a valuable tool for high-throughput screening of potential drugs that might influence its function. As such, the ongoing research surrounding CCRL2 is poised to significantly advance the field of immunology and therapeutic development, potentially leading to innovative strategies for managing inflammation and immune-related disorders.